Study at a glance
How was vitamin D tested for inflammation in adults with low levels?
Researchers randomly assigned 65 adults aged 18 to 60 to vitamin D or a placebo, a treatment without vitamin D. Participants had low vitamin D levels and overweight or obesity. The trial lasted 16 weeks. The reported analysis included 54 participants who followed the required study steps.
Did raising vitamin D levels improve signs of inflammation?
Vitamin D blood levels rose from about 31 to 88 nmol/L in the supplement group, while changing little with placebo. Despite this rise, vitamin D did not clearly improve the measured signs of inflammation compared with placebo. An immune-cell signalling measurement decreased in both groups, so the decrease could not be credited to vitamin D alone.
Does this rule out every effect of vitamin D on inflammation?
Raising a low vitamin D blood level did not automatically improve the inflammatory measurements studied. This does not prove that vitamin D has no effect on inflammation anywhere in the body. The trial measured selected outcomes, rather than every tissue, long-term immune function or inflammatory disease. Some substances were too low for the tests to measure reliably.
Do these studies establish a treatment for inflammation?
The trial was small, and inflammation was not its main outcome. It could not rule out every possible effect. In a separate, longer analysis from the trial called VITAL involving older people, one inflammation marker was lower at two years but not at four years. Other inflammatory substances showed no consistent benefit. These results do not establish an anti-inflammatory treatment, supplement dose or target blood level.
Read the full article below ↓A randomised trial in adults with low vitamin D concentrations and overweight or obesity found that supplementation raised vitamin D status but did not clearly improve the measured inflammatory outcomes over 16 weeks. This is a useful test of the assumption that correcting low status must reduce inflammation. The result did not support that assumption for the outcomes studied. Read the companion Vitamin D Supplementation and Low-Grade Inflammation in Deficient Adults: Full Study.
The study in brief
Mousa and colleagues randomised 65 adults aged 18 to 60 years with body mass index at least 25 kg/m² and 25-hydroxyvitamin D no higher than 50 nmol/L. The per-protocol analysis included 54 participants. The research regimen used a loading dose followed by daily supplementation; it is not a personal dosing recommendation.
Mean 25-hydroxyvitamin D rose from about 31.4 to 88.4 nmol/L in the vitamin D group, compared with 34.2 to 36.1 nmol/L with placebo. The intervention therefore changed the measured vitamin D status substantially. Vitamin D Status vs Vitamin D Effect explains why this exposure result must be separated from the downstream biological outcome.
What happened to inflammation?
There was no clear between-group improvement in high-sensitivity C-reactive protein or NF-κB activity. NF-κB declined in both groups, so a before-and-after reduction in the supplemented participants cannot be credited to vitamin D alone. The placebo comparison is essential to the interpretation.
Other cytokine results did not establish a coherent anti-inflammatory benefit. Some analytes were undetectable in many samples, limiting what could be concluded about them. An assay’s inability to quantify a marker is not evidence that the biological process was absent.
These results concern selected measurements relevant to Vitamin D and Chronic Inflammation. They do not measure every inflamed tissue, long-term immune function or inflammatory disease event. The signalling result is likewise a specific human measurement, not a refutation of every laboratory mechanism discussed in Vitamin D and Inflammatory Signalling.
How certain is the result?
The study’s randomised design and substantial rise in vitamin D status are strengths. Its small analysed sample, per-protocol analysis and secondary inflammatory outcomes limit precision. It did not demonstrate benefit, but it was not an equivalence trial proving that every possible effect was zero.
A longer VITAL biomarker analysis provides context. In that different, older population, vitamin D was associated with lower hs-CRP at two years, but the finding was not sustained at four years and there was no consistent beneficial cytokine pattern. The two studies should not be treated as identical tests or combined into a universal verdict.
The results do not establish correction of the excessive immune activity discussed in Vitamin D and Immune Overactivation. Nor did the study show that oxidative stress mediated its measured responses; Vitamin D and Oxidative Stress explains that related physiological topic. Differences in population and duration matter when comparing this trial with VITAL; Why Vitamin D Results Differ provides context for interpreting those differences without turning either study into a universal verdict.
Conclusion
Raising vitamin D status did not automatically reduce the measured inflammatory responses in this deficient population. The evidence supports outcome-specific interpretation rather than an anti-inflammatory treatment claim. It does not establish a supplement dose, a target blood concentration or an effect on Vitamin D and Immune Ageing.
This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.
Primary source and publication details
Related reading
Association between the atherogenic index of plasma and abdominal aortic calcification in adults: a cross-sectional study
However, there are no studies that have examined the relationship between AIP index and AAC, so we investigated the potential association between them in the general population.
Original paper ↗Read more →Association Between Vitamin D and Hyperuricemia Among Adults in the United States
All dietary intakes were evaluated through 24-h dietary recalls.
Original paper ↗Read more →Association between weight-adjusted waist index and myopia in adolescents and young adults: results from NHANES 1999 to 2008
The objective of this study was to investigate the correlation between a new measure of obesity, the weight-adjusted waist index (WWI), and myopia.
Original paper ↗Read more →Association of Low Free T3 with Disease Presence and Activity in Ankylosing Spondylitis
The objective of this study is to evaluate the relationship between serum FT3 levels and both the presence and clinical activity of AS, while also examining other endocrine-metabolic parameters.
Original paper ↗Read more →Dietary quality in a sample of adults with type 2 diabetes mellitus in Ireland; a cross-sectional case control study
The aim of this study was to determine the dietary quality of individuals with type 2 diabetes mellitus (T2DM) using a variety of validated DQIs.
Original paper ↗Read more →Effect of adjunctive single high-dose vitamin D3 on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial
However, no trials have examined the effect of adjunctive vitamin D therapy on outcomes in adults with community-acquired pneumonia (CAP).
Original paper ↗Read more →Expert-Reviewed Nutritional Guidance for Adults with Spinal Cord Injury: A Delphi Study
Nutritional needs for people with chronic spinal cord injury (SCI) are inadequately addressed due to the lack of comprehensive evidence and scattered research.
Original paper ↗Read more →Exposure to volatile organic compounds and sarcopenia risk in US adults based on NHANES
This study investigates the association between volatile organic compounds (VOCs) and sarcopenia in a cohort of 3,391 U.S.
Original paper ↗Read more →Genetic Variant in Leptin rs7799039 Is Associated with Total Body Mineral Estimates, but Not with Fat Mass, in Young Healthy Adults
Background/Objectives: The aim of this study was to investigate the association between the rs7799039 variant in the leptin (LEP) gene and specific parameters of body composition in young healthy Slovak adults using bioelectrical impedance analysis.
Original paper ↗Read more →Individual nutrients and serum klotho levels in adults aged 40 to 79 years
The final study sample consisted of 2637 participants (mean age 59.0 ± 10.7 years; 52% women).
Original paper ↗Read more →Low vitamin D status strongly associated with periodontitis in Puerto Rican adults
The aim of this pilot study was to evaluate the association between vitamin D levels and periodontal disease in Puerto Rican adults.
Original paper ↗Read more →Moderate Amounts of Vitamin D3 in Supplements are Effective in Raising Serum 25-Hydroxyvitamin D from Low Baseline Levels in Adults: A Systematic Review
Published literature was searched for relevant articles describing randomized controlled trials.
Original paper ↗Read more →Needle-Free Bedside and Anthropometric Measures Show Weak Discrimination of an Adverse Blood-Biomarker Profile in Middle-Aged and Older Mexican Adults: An Internally Validated Machine-Learning Study
This study aimed to determine whether machine-learning algorithms can predict such a profile from a defined set of needle-free bedside and anthropometric measures in Mexican adults.
Original paper ↗Read more →Prevalence and risk factors of myopia in adult Korean population: Korea national health and nutrition examination survey 2013-2014 (KNHANES VI)
To evaluate the prevalence and risk factors of myopia in adult Korean population.
Original paper ↗Read more →The Associations of Cardiometabolic and Dietary Variables with Clinical Periodontitis in Adults with and without Type 2 Diabetes: A Cross-Sectional Study
Participants provided fasting blood samples and 24-h diet recalls on at least two different days.
Original paper ↗Read more →The Relationship Between Diet and the Neuropathological Hallmarks of Alzheimer’s Disease in Cognitively Normal Adults: A Systematic Narrative Review
Future research would benefit from greater consensus in methodology and should prioritize prospective cohort and randomized trial designs.
Original paper ↗Read more →Vitamin D levels among children, adolescents, adults, and elders in Pakistani population: a cross-sectional study
They were examined for laboratory findings of serum 25 hydroxyvitamin D levels to determine vitamin D deficiency, insufficiency, and sufficiency among all age groups of both male and female genders.
Original paper ↗Read more →Vitamin D levels and platelet status in healthy children and adolescent
This study aimed to verify if serum levels of 25(OH)D, platelet count, and mean platelet volume (MPV), are associated in children and adolescents aged 6 to 17 years old.
Original paper ↗Read more →Vitamin D levels in children with familial Mediterranean fever
This study aimed to determine whether vitamin D deficiency is more common in children with familial Mediterranean fever (FMF) than in healthy individuals.
Original paper ↗Read more →Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial
Yet, no trials have examined the effects of vitamin D supplementation on NFκB activity in-vivo in humans.
Original paper ↗Read more →Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Original paper ↗Read more →Original sources
Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial
Yet, no trials have examined the effects of vitamin D supplementation on NFκB activity in-vivo in humans.
Publication details
Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Aya Mousa, Negar Naderpoor, Josphin Johnson, Karly Sourris, Maximilian P J de Courten, Kirsty Wilson, Robert Scragg, Magdalena Plebanski, Barbora de Courten. Scientific Reports; 2017; 7; 15154. DOI: 10.1038/s41598-017-15264-1. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Publication details
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Yanbin Dong, Haidong Zhu, Li Chen, Ying Huang, William Christen, Nancy R Cook, Trisha Copeland, Samia Mora, Julie E Buring, I-Min Lee, Karen H Costenbader, JoAnn E Manson. Nutrients; 2022; 14; 24; 5307. DOI: 10.3390/nu14245307. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.